239 related articles for article (PubMed ID: 19047001)
1. Pupillometric findings in patients with Parkinson's disease and cognitive disorder.
Stergiou V; Fotiou D; Tsiptsios D; Haidich B; Nakou M; Giantselidis C; Karlovasitou A
Int J Psychophysiol; 2009 May; 72(2):97-101. PubMed ID: 19047001
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic deficiency in Alzheimer's and Parkinson's disease: evaluation with pupillometry.
Fotiou DF; Stergiou V; Tsiptsios D; Lithari C; Nakou M; Karlovasitou A
Int J Psychophysiol; 2009 Aug; 73(2):143-9. PubMed ID: 19414041
[TBL] [Abstract][Full Text] [Related]
3. Effect of age on pupillary light reflex: evaluation of pupil mobility for clinical practice and research.
Fotiou DF; Brozou CG; Tsiptsios DJ; Fotiou A; Kabitsi A; Nakou M; Giantselidis C; Goula A
Electromyogr Clin Neurophysiol; 2007; 47(1):11-22. PubMed ID: 17375877
[TBL] [Abstract][Full Text] [Related]
4. Pupil light reflex in Parkinson's disease: evaluation with pupillometry.
Giza E; Fotiou D; Bostantjopoulou S; Katsarou Z; Karlovasitou A
Int J Neurosci; 2011 Jan; 121(1):37-43. PubMed ID: 21034369
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cholinergic hypothesis in Alzheimer's disease with neuropsychological methods.
Fotiou D; Kaltsatou A; Tsiptsios D; Nakou M
Aging Clin Exp Res; 2015 Oct; 27(5):727-33. PubMed ID: 25749905
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pupil mobility in patients with myasthenia gravis.
Tsiptsios D; Fotiou DF; Haidich AB; Brozou GC; Nakou M; Giantselidis C; Karlovasitou A; Fotiou F
Electromyogr Clin Neurophysiol; 2008; 48(5):209-18. PubMed ID: 18754530
[TBL] [Abstract][Full Text] [Related]
7. Pupillometric characteristics in patients with choroidal neovascularization due to age-related macular degeneration.
Brozou C; Fotiou D; Androudi S; Theodoridou E; Giantselidis C; Alexandridis A; Brazitikos P
Eur J Ophthalmol; 2009; 19(2):254-62. PubMed ID: 19253243
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of cognitive impairment in a population of patients with Parkinson's disease by means of the mini mental Parkinson test].
Parrao-Díaz T; Chaná-Cuevas P; Juri-Claverías C; Kunstmann C; Tapia-Núñez J
Rev Neurol; 2005 Mar 16-31; 40(6):339-44. PubMed ID: 15795869
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
[TBL] [Abstract][Full Text] [Related]
11. Application of depression criteria (DSM-IV) in patients with Parkinson's disease.
Gómez-Esteban JC; Tijero B; Somme J; Bilbao I; Fernández J; Boyero S; Velasco F; Lezcano E; Zarranz JJ
Clin Neurol Neurosurg; 2009 Oct; 111(8):665-9. PubMed ID: 19589638
[TBL] [Abstract][Full Text] [Related]
12. Lack of a relationship between the pupillary light reflex response and state/trait anxiety in remitted patients with panic disorder.
Shioiri T; Kuwabara H; Abe R; Iijima A; Kojima-Maruyama M; Kitamura H; Bando T; Someya T
J Affect Disord; 2006 Oct; 95(1-3):159-64. PubMed ID: 16762420
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
14. Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease.
McKinlay A; Grace RC; Dalrymple-Alford JC; Roger D
Dement Geriatr Cogn Disord; 2009; 28(2):121-9. PubMed ID: 19690414
[TBL] [Abstract][Full Text] [Related]
15. Relationship between clinical phenotypes and cognitive impairment in Parkinson's disease (PD).
Oh JY; Kim YS; Choi BH; Sohn EH; Lee AY
Arch Gerontol Geriatr; 2009; 49(3):351-4. PubMed ID: 19136159
[TBL] [Abstract][Full Text] [Related]
16. Cognitive decline in Parkinson's disease: a prospective longitudinal study.
Muslimović D; Post B; Speelman JD; De Haan RJ; Schmand B
J Int Neuropsychol Soc; 2009 May; 15(3):426-37. PubMed ID: 19402929
[TBL] [Abstract][Full Text] [Related]
17. Depression impairs executive functioning in Parkinson disease patients with low educational level.
Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment as a central cholinergic deficit in patients with Myasthenia Gravis.
Kaltsatou A; Fotiou D; Tsiptsios D; Orologas A
BBA Clin; 2015 Jun; 3():299-303. PubMed ID: 26672759
[TBL] [Abstract][Full Text] [Related]
19. [Neuropsychiatric problems in patients with Parkinson's disease].
Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
[TBL] [Abstract][Full Text] [Related]
20. Cognitive decline in early Parkinson's disease.
Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
